Fonar PE Ratio 2012-2025 | FONR
Current and historical p/e ratio for Fonar (FONR) from 2012 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Fonar PE ratio as of January 09, 2026 is 16.71.
| Fonar PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-01-12 | 18.59 | 16.75 | |
| 2025-09-30 | 15.06 | $1.11 | 13.57 |
| 2025-06-30 | 14.96 | $1.23 | 12.16 |
| 2025-03-31 | 14.01 | $1.25 | 11.21 |
| 2024-12-31 | 15.14 | $1.15 | 13.17 |
| 2024-09-30 | 16.19 | $1.40 | 11.56 |
| 2024-06-30 | 16.00 | $1.53 | 10.46 |
| 2024-03-31 | 21.36 | $1.56 | 13.69 |
| 2023-12-31 | 19.56 | $1.84 | 10.63 |
| 2023-09-30 | 15.40 | $1.62 | 9.51 |
| 2023-06-30 | 17.10 | $1.32 | 12.95 |
| 2023-03-31 | 16.20 | $1.16 | 13.97 |
| 2022-12-31 | 16.75 | $0.93 | 18.01 |
| 2022-09-30 | 14.15 | $1.18 | 11.99 |
| 2022-06-30 | 15.19 | $1.44 | 10.55 |
| 2022-03-31 | 18.55 | $1.44 | 12.88 |
| 2021-12-31 | 14.98 | $1.66 | 9.02 |
| 2021-09-30 | 15.46 | $1.53 | 10.10 |
| 2021-06-30 | 17.68 | $1.34 | 13.19 |
| 2021-03-31 | 18.09 | $1.42 | 12.74 |
| 2020-12-31 | 17.36 | $1.06 | 16.38 |
| 2020-09-30 | 20.88 | $1.06 | 19.70 |
| 2020-06-30 | 21.37 | $1.17 | 18.26 |
| 2020-03-31 | 14.62 | $1.75 | 8.35 |
| 2019-12-31 | 19.69 | $2.13 | 9.24 |
| 2019-09-30 | 20.67 | $2.20 | 9.40 |
| 2019-06-30 | 21.51 | $2.21 | 9.73 |
| 2019-03-31 | 20.47 | $2.99 | 6.85 |
| 2018-12-31 | 20.24 | $2.94 | 6.88 |
| 2018-09-30 | 24.90 | $3.04 | 8.19 |
| 2018-06-30 | 26.55 | $3.10 | 8.56 |
| 2018-03-31 | 29.80 | $2.53 | 11.78 |
| 2017-12-31 | 24.35 | $2.90 | 8.40 |
| 2017-09-30 | 30.50 | $2.92 | 10.45 |
| 2017-06-30 | 27.75 | $2.92 | 9.50 |
| 2017-03-31 | 17.55 | $3.01 | 5.83 |
| 2016-12-31 | 19.15 | $2.58 | 7.42 |
| 2016-09-30 | 20.54 | $2.48 | 8.28 |
| 2016-06-30 | 20.36 | $2.37 | 8.59 |
| 2016-03-31 | 15.38 | $2.27 | 6.78 |
| 2015-12-31 | 17.26 | $2.13 | 8.10 |
| 2015-09-30 | 13.41 | $2.00 | 6.71 |
| 2015-06-30 | 10.58 | $1.95 | 5.43 |
| 2015-03-31 | 13.04 | $1.71 | 7.63 |
| 2014-12-31 | 10.40 | $1.66 | 6.27 |
| 2014-09-30 | 11.01 | $1.59 | 6.92 |
| 2014-06-30 | 12.20 | $1.58 | 7.72 |
| 2014-03-31 | 17.58 | $1.70 | 10.34 |
| 2013-12-31 | 21.21 | $1.61 | 13.17 |
| 2013-09-30 | 5.77 | $1.49 | 3.87 |
| 2013-06-30 | 6.56 | $1.34 | 4.90 |
| 2013-03-31 | 6.92 | $0.82 | 8.44 |
| 2012-12-31 | 4.33 | $0.85 | 5.09 |
| 2012-09-30 | 3.75 | $0.88 | 4.26 |
| 2012-06-30 | 4.10 | $0.90 | 4.56 |
| 2012-03-31 | 2.68 | $0.72 | 3.72 |
| 2011-12-31 | 1.70 | $0.72 | 2.36 |
| 2011-09-30 | 1.96 | $0.72 | 2.72 |
| 2011-06-30 | 1.96 | $0.55 | 3.56 |
| 2011-03-31 | 1.68 | $0.52 | 3.23 |
| 2010-12-31 | 1.30 | $0.32 | 4.06 |
| 2010-09-30 | 1.39 | $-0.18 | 0.00 |
| 2010-06-30 | 1.47 | $-0.60 | 0.00 |
| 2010-03-31 | 1.91 | $-0.62 | 0.00 |
| 2009-12-31 | 1.57 | $-0.62 | 0.00 |
| 2009-09-30 | 2.14 | $-0.36 | 0.00 |
| 2009-06-30 | 1.90 | $-0.01 | 0.00 |
| 2009-03-31 | 0.84 | 0 | 0.00 |
| 2008-12-31 | 0.83 | 0 | 0.00 |
| 2008-09-30 | 1.18 | 0 | 0.00 |
| 2008-06-30 | 2.25 | 0 | 0.00 |
| 2008-03-31 | 3.81 | 0 | 0.00 |
| 2007-12-31 | 5.20 | 0 | 0.00 |
| 2007-09-30 | 6.71 | 0 | 0.00 |
| 2007-06-30 | 4.97 | 0 | 0.00 |
| 2007-03-31 | 6.50 | 0 | 0.00 |
| 2006-12-31 | 7.00 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.115B | $0.104B |
| FONAR Corporation is a developer and manufacturer of MRI scanners. The Company has introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's stellar product is the UPRIGHT MRI, also known as the Stand-Up MRI, the whole-body MRI that performs Position imaging and scans patients in numerous weight-bearing positions like standing, sitting, in flexion and extension, as well as the conventional lie-down position. The Company's subsidiary, Health Management Corporation of America, is a physician practice management company providing management services to medical providers. FONAR Corporation is based in Melville, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $218.959B | 25.23 |
| EssilorLuxottica (ESLOY) | France | $150.458B | 0.00 |
| Boston Scientific (BSX) | United States | $144.746B | 33.10 |
| Stryker (SYK) | United States | $140.556B | 27.91 |
| Medtronic (MDT) | Ireland | $125.035B | 17.32 |
| Medline (MDLN) | United States | $53.232B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.704B | 0.00 |
| Agilent Technologies (A) | United States | $42.105B | 26.62 |
| GE HealthCare Technologies (GEHC) | United States | $39.758B | 19.01 |
| ResMed (RMD) | United States | $36.846B | 25.50 |
| Koninklijke Philips (PHG) | Netherlands | $28.483B | 18.60 |
| Terumo (TRUMY) | Japan | $21.735B | 24.47 |
| Insulet (PODD) | United States | $20.333B | 63.11 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.401B | 11.48 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.263B | 0.00 |
| Baxter (BAX) | United States | $10.831B | 8.74 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.735B | 31.41 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.480B | 13.65 |
| BillionToOne (BLLN) | United States | $3.933B | 0.00 |
| Envista Holdings (NVST) | United States | $3.885B | 22.29 |
| Haemonetics (HAE) | United States | $3.840B | 17.09 |
| ICU Medical (ICUI) | United States | $3.777B | 23.98 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.086B | 14.07 |
| QuidelOrtho (QDEL) | United States | $2.286B | 14.69 |
| Neogen (NEOG) | United States | $2.093B | 45.81 |
| Perrigo (PRGO) | Ireland | $2.075B | 5.20 |
| AtriCure (ATRC) | United States | $2.061B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.928B | 38.81 |
| Curaleaf Holdings (CURLF) | Canada | $1.716B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.680B | 73.64 |
| Phibro Animal Health (PAHC) | United States | $1.599B | 15.97 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.577B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.425B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.421B | 20.57 |
| BioLife Solutions (BLFS) | United States | $1.197B | 355.14 |
| Capricor Therapeutics (CAPR) | United States | $1.090B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.031B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.005B | 0.00 |
| InMode (INMD) | Israel | $0.913B | 10.31 |
| Omeros (OMER) | United States | $0.886B | 0.00 |
| CeriBell (CBLL) | United States | $0.865B | 0.00 |
| Valneva SE (VALN) | France | $0.850B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.563B | 15.26 |
| Verano Holdings (VRNO) | United States | $0.461B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.453B | 0.00 |
| Brainsway (BWAY) | Israel | $0.453B | 77.03 |
| Cresco Labs (CRLBF) | United States | $0.443B | 0.00 |
| SNDL (SNDL) | Canada | $0.436B | 0.00 |
| Cerus (CERS) | United States | $0.396B | 0.00 |
| Quanterix (QTRX) | United States | $0.376B | 0.00 |
| Evolus (EOLS) | United States | $0.366B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.290B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.275B | 21.94 |
| Sanuwave Health (SNWV) | United States | $0.266B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.242B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.240B | 141.00 |
| High Tide (HITI) | Canada | $0.234B | 0.00 |
| Organigram Global (OGI) | Canada | $0.232B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.217B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Vireo Growth (VREOF) | United States | $0.208B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.192B | 16.92 |
| Accendra Health (ACH) | United States | $0.190B | 1.91 |
| OraSure Technologies (OSUR) | United States | $0.189B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.154B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.145B | 0.00 |
| Exagen (XGN) | United States | $0.144B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.137B | 0.00 |
| Apyx Medical (APYX) | United States | $0.133B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.118B | 0.00 |
| Biote (BTMD) | United States | $0.118B | 5.16 |
| MacroGenics (MGNX) | United States | $0.116B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 24.98 |
| Sharps Technology (STSS) | United States | $0.055B | 0.00 |
| Nephros (NEPH) | United States | $0.051B | 37.00 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| Jin Medical (ZJYL) | China | $0.039B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.53 |
| Allurion Technologies (ALUR) | United States | $0.016B | 0.00 |
| Bonk (BNKK) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Flora Growth (FLGC) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |